Recruitment for this study has ended, so applications are closed. You can still read the trial details, or browse similar trials that are currently recruiting.
Sponsor:
Terry L. Wahls
Code:
NCT05057676
Conditions
Multiple Sclerosis
Clinically Isolated Syndrome
Fibromyalgia
Post Acute Sequelae of COVID-19
Cancer in Remission With Persisting Fatigue
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Immediate Autoimmune Intervention Mastery Course (AIM)
Immediate Question and Answer sessions. (AIM Q and A sessions)
Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
Delayed AIM Question and Answer sessions
Brief summary:
Conditions
Multiple Sclerosis
Clinically Isolated Syndrome
Fibromyalgia
Post Acute Sequelae of COVID-19
Cancer in Remission With Persisting Fatigue
Study ID
NCT05057676
Start date
Dec 1, 2021
Status verified date
Aug, 2026
Completion date
Dec 1, 2027
Anticipated
Primary completion date
Dec 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
400 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Supportive Care
Arms
experimental: Intervention Autoimmune Intervention Mastery Course (AIM) online course
other: Delayed Autoimmune Intervention Mastery Course
Interventions
Immediate Autoimmune Intervention Mastery Course (AIM)
Immediate Question and Answer sessions. (AIM Q and A sessions)
Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
Delayed AIM Question and Answer sessions
Primary outcome measure
Sponsor
Terry L. Wahls
Last update posted
Aug 10, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-11. This information was provided to ClinicalTrials.gov by Terry L. Wahls on 2026-08-10.